No Data
No Data
The list of preferred chip stocks for 2025 has been revealed! In addition to NVIDIA and Broadcom, Wall Street's major firms are also bullish on these companies.
Analysts at Bank of America expect the overall sales of the Semiconductors market to grow by about 15% in 2025, building on the strong growth projected for 2024, reaching 725 billion dollars. Although this growth rate is slower compared to this year's forecast of 20%, it remains very strong and robust.
Saying one thing and doing another? Europe's imports of Russian LNG have reached a record high.
The EU vows to eliminate its dependence on Russian chemical fuels, but ultimately cannot resist the temptation of Low Stock Price. However, to appease Trump, Europe may increase imports from the USA going forward.
Buckle up! Goldman Sachs: Market optimism is nearing its peak, Bullish on two defensive Sectors.
①Goldman Sachs advises investors to take more "defensive measures" as Wall Street's optimism about the USA economy and stock market approaches historical highs. ②Goldman Sachs' model is bullish on the performance of defensive stocks such as utilities and Medical Care.
Bristol-Myers Squibb (BMY.US) TYK2 inhibitors have achieved the primary endpoints in two key phase 3 clinical trials.
Bristol-Myers Squibb (BMY.US) announced today the positive results of the POETYK PsA-1 and POETYK PsA-2 trials. These two key Phase 3 clinical trials evaluated the efficacy and safety of the tyrosine kinase 2 (TYK2) inhibitor Sotyktu (deucravacitinib) in adult patients with active psoriatic arthritis (PsA).
Schwab US Dividend Equity ETF Reverses In December: What's Going On?
Bristol Myers Squibb's Sotyktu Shows Results in Psoriatic Arthritis Trials